Viatris (VTRS) Other Non-Current Liabilities (2019 - 2026)

Viatris' (VTRS) quarterly Other Non-Current Liabilities came in at $2.1 billion in Q1 2026, up 12.91% year-on-year from $1.8 billion in Q1 2025, and up 3.36% quarter-over-quarter from $2.0 billion in Q4 2025.

Viatris (VTRS) Other Non-Current Liabilities (2019 - 2026) Analysis & Trends

Viatris' Other Non-Current Liabilities history runs 8 years deep, the most recent figure standing at $2.1 billion for Q1 2026.

  • On a quarterly basis, Other Non-Current Liabilities rose 12.91% year-over-year to $2.1 billion in Q1 2026; TTM through Mar 2026 was $2.1 billion, a 12.91% increase from a year earlier, with the FY2025 full-year figure at $2.0 billion, up 3.9% from the prior year.
  • Other Non-Current Liabilities climbed to $2.1 billion in Q1 2026 per VTRS's latest filing, from $2.0 billion in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $2.1 billion in Q1 2026 and bottomed at $345.0 million in Q1 2024.
  • The 5-year median for Other Non-Current Liabilities is $1.8 billion (2022), against an average of $1.6 billion.
  • Across the five-year window, Other Non-Current Liabilities slumped 79.94% in 2024 and surged 434.61% in 2025, its largest moves.
  • Year by year, Other Non-Current Liabilities stood at $1.8 billion in 2022, then declined by 13.64% to $1.5 billion in 2023, then grew by 27.84% to $1.9 billion in 2024, then increased by 3.9% to $2.0 billion in 2025, then increased by 3.36% to $2.1 billion in 2026.
  • Per Business Quant, the three latest VTRS Other Non-Current Liabilities figures stand at $2.1 billion (Q1 2026), $2.0 billion (Q4 2025), and $1.8 billion (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Vireo Growth 10.57 Bn 10.41 Bn 59.30 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 2.08 Bn
Dec 31, 2025 2.01 Bn
Sep 30, 2025 1.82 Bn
Jun 30, 2025 1.84 Bn
Mar 31, 2025 1.84 Bn
Dec 31, 2024 1.94 Bn
Sep 30, 2024 1.87 Bn
Jun 30, 2024 345.00 Mn
Mar 31, 2024 345.00 Mn
Dec 31, 2023 1.52 Bn
Sep 30, 2023 1.65 Bn
Jun 30, 2023 1.67 Bn
Mar 31, 2023 1.72 Bn
Dec 31, 2022 1.76 Bn
Sep 30, 2022 1.75 Bn
Jun 30, 2022 1.81 Bn
Mar 31, 2022 1.88 Bn
Dec 31, 2021 1.93 Bn
Sep 30, 2021 2.05 Bn
Jun 30, 2021 2.24 Bn